Ubs Asset Management Americas Inc Erasca, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Erasca, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 444,769 shares of ERAS stock, worth $636,019. This represents 0.0% of its overall portfolio holdings.
Number of Shares
444,769
Previous 364,085
22.16%
Holding current value
$636,019
Previous $993,000
12.39%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ERAS
# of Institutions
153Shares Held
227MCall Options Held
10.9KPut Options Held
65.1K-
Frazier Life Sciences Management, L.P. Menlo Park, CA19.4MShares$27.7 Million2.92% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.7MShares$23.9 Million0.03% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$23.2 Million6.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$18.1 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA12.5MShares$17.9 Million4.12% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $175M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...